Emergent BioSolutions Inc (NYSE:EBS)
$ 10.69 -0.2 (-1.84%) Market Cap: 579.23 Mil Enterprise Value: 1.38 Bil PE Ratio: 0 PB Ratio: 1.46 GF Score: 63/100

Q2 2020 Emergent BioSolutions Inc Earnings Call Transcript

Jul 30, 2020 / 09:00PM GMT
Release Date Price: $97.02 (+2.96%)
Operator

Ladies and gentlemen, thank you for standing by, and welcome to the Emergent BioSolutions Q2 Earnings Conference Call. (Operator Instructions)

I would now like to hand the conference to Emergent BioSolutions. Please go ahead.

Robert G. Burrows
Emergent BioSolutions Inc. - VP of IR

Thank you, Joelle, and good afternoon, everyone. My name is Bob Burrows, Vice President of Investor Relations for Emergent. Thank you for joining us today as we discuss the operational and financial results for the second quarter and 6 months ended June 30, 2020. As is customary, today's call is open to all participants and, in addition, the call is being recorded and is copyrighted by Emergent BioSolutions.

The agenda for today's call will follow a traditional path with prepared comments from Bob Kramer, President and Chief Executive Officer; and Rich Lindahl, Chief Financial Officer. Other members of the senior team are present and available during the Q&A session following our prepared comments.

Before beginning, during today's call, either on our

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot